KASID
Search
- Page Path
- HOME > Search
Original Articles
- Burden of inflammatory bowel disease in India: analysis of the Global Burden of Disease study from 1990 to 2019
- Suprabhat Giri, Anuraag Jena, Praveen Kumar-M, Jaikumar Rajavoor Muniswamy, Preetam Nath, Vishal Sharma
- Received August 26, 2024 Accepted December 4, 2024 Published online February 6, 2025
- DOI: https://doi.org/10.5217/ir.2024.00134 [Epub ahead of print]
-
Abstract
PDF
PubReader
ePub - Background/Aims
Inflammatory bowel disease (IBD) is increasing across the globe, more so in populous countries like India. We aimed to study the disease burden and epidemiological trends of IBD in India and look closer into the disease pattern across the country from 1990 to 2019.
Methods
The burden of IBD was estimated in India using the data from the Global Burden of Disease estimate for 2019, which is a comprehensive worldwide project. The analysis included various parameters like incidence, prevalence, mortality, disability-adjusted life years, years lived with disability, and years of life lost as age-adjusted rates (per 100,000 population). Using modeling, the prediction was also made for 2050 in India.
Results
The age-standardized incidence, prevalence, mortality, and disability rates of IBD in India for 2019 were 2.34, 20.34, 0.40, and 13.04, respectively. These are lower than the global incidence, prevalence, mortality, and disability rates of 4.97, 59.25, 0.54, and 20.15, respectively. The annual rates of change in incidence, prevalence, mortality, and disability rates in India from 1990 to 2019 were 0.05, –0.02, –0.36, and –0.35, respectively. The annual rates of change in incidence and prevalence are higher than the global rate of –0.18 and –0.19, while the annual rates of change in mortality and disability are lower than the global rate of –0.19 and –0.26.
Conclusions
The incidence and prevalence of IBD in India are lower compared to the global population but are increasing at a faster rate than the global population.
- 1,906 View
- 224 Download
- IBD
- Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
- Anupam K. Singh, Anuraag Jena, Praveen Kumar-M, Daya Krishna Jha, Vishal Sharma
- Intest Res 2022;20(1):134-143. Published online January 18, 2021
- DOI: https://doi.org/10.5217/ir.2020.00108
-
Abstract
PDF
Supplementary MaterialPubReaderePub - Background/Aims
Coronavirus disease 2019 (COVID-19) is recognized to have variable clinical manifestations. The clinical presentation of patients with inflammatory bowel disease (IBD) having COVID-19 is unclear.
Methods
We identified articles reporting about the clinical presentation of COVID-19 in those with underlying IBD from PubMed and Embase. The studies, irrespective of design or language, were included. The overall pooled frequency of various symptoms was estimated. Joanna Briggs Institute Critical appraisal checklist was used to assess the quality of studies.
Results
Eleven studies, including 1,325 patients, were included in the pooled analysis. The pooled estimates for clinical presentation were; fever: 67.53% (95% confidence interval [CI], 45.38–83.88), cough: 59.58% (95% CI, 45.01–72.63), diarrhea: 27.26% (95% CI, 19.51–36.69), running nose: 27% (95% CI, 15.26–43.19) and dyspnea: 25.29% (95% CI, 18.52–33.52). The pooled prevalence rates for abdominal pain, nausea and vomiting were 13.08% (95% CI, 9.24–18.19), 10.08% (95% CI, 5.84–16.85) and 8.80% (95% CI, 4.43–16.70) per 100 population, respectively.
Conclusions
The clinical presentation of COVID-19 in IBD patients is similar to the general population. -
Citations
Citations to this article as recorded by
- Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease
Amin Alirezaylavasani, Ingrid Marie Egner, Børresdatter Dahl, Adity Chopra, Taissa de Matos Kasahara, Guro Løvik Goll, Jørgen Jahnsen, Gunnveig Grødeland, John Torgils Vaage, Fridtjof Lund-Johansen, Jan Cato Holter, Bente Halvorsen, Kristin Kaasen Jørgens
Clinical Immunology.2025; 271: 110404. CrossRef - Small Bowel Diverticulosis and COVID-19: Awareness Is the Key: A Case Series and Review of the Literature
Petros Bangeas, Nikolaos Konstantinidis, Tania Chrisopoulou, Despoina Karatzia, Alexandros Giakoustidis, Vasileios Papadopoulos
Medicina.2024; 60(2): 229. CrossRef - Exacerbated gastrointestinal symptoms and long COVID in IBD patients with SARS-CoV-2 infection: A multi-center study from taiwan
Tsung-Yu Tsai, Jia-Feng Wu, Meng-Tzu Weng, Chiao-Hsiung Chuang, Tien-Yu Huang, Wei-Chen Tai, Chi-Ming Tai, Chen-Shuan Chung, Chih-Cheng Chen, Ching-Pin Lin, Yuan-Yao Tsai, Shu-Chen Wei
Journal of the Formosan Medical Association.2024; 123(8): 866. CrossRef - COVID-19 IN INFLAMMATORY BOWEL DISEASE: SHOULD WE BE MORE CAREFUL WITH THE USE OF SALICYLATES?
Mariana Rolim Fernandes MACEDO, Carlos Arthur Fernandes SOBREIRA, Carola Braz de LAVOR, Camila Ribeiro RÔLA, Ticiana Maria de Lavor ROLIM, Francisco Sérgio Rangel de Paula PESSOA, Milena Santana GIRÃO, Caio César Furtado FREIRE, Ranna Caroline Bezerra SIE
Arquivos de Gastroenterologia.2024;[Epub] CrossRef - Impact of preexisting digestive problems on the gastrointestinal symptoms of patients with omicron variant of SARS-CoV-2 infection
Xinghuang Liu, Bayasgalan Luvsandagva, Dongke Wang, Siran Zhu, Zhiyue Xu, Dan Zhou, Xiaotian Xie, Wei Qian, Xiaohua Hou, Tao Bai, Dong Keon Yon
PLOS ONE.2024; 19(10): e0312545. CrossRef - Diarrhea and Coronavirus Disease 2019 Infection
David M. Friedel, Mitchell S. Cappell
Gastroenterology Clinics of North America.2023; 52(1): 59. CrossRef - Managing IBD in the COVID-19 era
Nicholas Scalzo, Ryan C. Ungaro
Therapeutic Advances in Gastroenterology.2023;[Epub] CrossRef - Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients
Alfredo Papa, Marcello Covino, Sara Sofia De Lucia, Angelo Del Gaudio, Marcello Fiorani, Giorgia Polito, Carlo Romano Settanni, Andrea Piccioni, Francesco Franceschi, Antonio Gasbarrini
World Journal of Gastroenterology.2023; 29(26): 4099. CrossRef - Twelve Months with COVID-19: What Gastroenterologists Need to Know
Giulia Concas, Michele Barone, Ruggiero Francavilla, Fernanda Cristofori, Vanessa Nadia Dargenio, Rossella Giorgio, Costantino Dargenio, Vassilios Fanos, Maria Antonietta Marcialis
Digestive Diseases and Sciences.2022; 67(7): 2771. CrossRef - Perceptions and Behaviors of Patients with Inflammatory Bowel Disease during the COVID-19 Crisis
Yoo Jin Lee, Kyeong Ok Kim, Min Cheol Kim, Kwang Bum Cho, Kyung Sik Park, Byeong Ik Jang
Gut and Liver.2022; 16(1): 81. CrossRef - Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
Simeng Lin, Louis HS Lau, Neil Chanchlani, Nicholas A Kennedy, Siew C Ng
Gut.2022; 71(7): 1426. CrossRef - Vaccination strategies for Korean patients with inflammatory bowel disease
Yoo Jin Lee, Eun Soo Kim
The Korean Journal of Internal Medicine.2022; 37(5): 920. CrossRef - Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung
Intestinal Research.2022; 20(4): 431. CrossRef - Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis
Ho Min Yong, Sung-Jo Park, Seong Ran Jeon, Heesu Park, Hyun Gun Kim, Tae Hee Lee, Junseok Park, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Hyeon Jeong Goong, Suyeon Park
Medicine.2021; 100(34): e27065. CrossRef - KASID Guidance for Clinical Practice Management of Adult Inflammatory Bowel Disease during the COVID-19 Pandemic: Expert Consensus Statement
Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung
The Korean Journal of Gastroenterology.2021; 78(2): 105. CrossRef - The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD
Giorgos Bamias, Georgios Kokkotis, Angeliki Christidou, Dimitrios K. Christodoulou, Vasileios Delis, Georgia Diamantopoulou, Smaragdi Fessatou, Anthia Gatopoulou, Olga Giouleme, Panagiota Kafritsa, Chrisostomos Kalantzis, Andreas Kapsoritakis, Pantelis Ka
European Journal of Gastroenterology & Hepatology.2021; 33(1S): e810. CrossRef
- Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease
- 7,693 View
- 432 Download
- 16 Web of Science
- 16 Crossref
First
Prev
